GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Charles River Laboratories International Inc (STU:RV6) » Definitions » 12-1 Month Momentum %

Charles River Laboratories International (STU:RV6) 12-1 Month Momentum % : 23.97% (As of May. 25, 2024)


View and export this data going back to . Start your Free Trial

What is Charles River Laboratories International 12-1 Month Momentum %?

12-1 Month Momentum % is the total return of the stock from 12-month ago to 1-month ago. As of today (2024-05-25), Charles River Laboratories International's 12-1 Month Momentum % is 23.97%.

The industry rank for Charles River Laboratories International's 12-1 Month Momentum % or its related term are showing as below:

STU:RV6's 12-1 Month Momentum % is ranked better than
82.76% of 232 companies
in the Medical Diagnostics & Research industry
Industry Median: -22.215 vs STU:RV6: 23.97

Competitive Comparison of Charles River Laboratories International's 12-1 Month Momentum %

For the Diagnostics & Research subindustry, Charles River Laboratories International's 12-1 Month Momentum %, along with its competitors' market caps and 12-1 Month Momentum % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Charles River Laboratories International's 12-1 Month Momentum % Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Charles River Laboratories International's 12-1 Month Momentum % distribution charts can be found below:

* The bar in red indicates where Charles River Laboratories International's 12-1 Month Momentum % falls into.



Charles River Laboratories International  (STU:RV6) 12-1 Month Momentum % Calculation

12-1 Month Momentum % is calculated as following:

12-1 Month Momentum %=( Price 1-month ago / Price 12-month ago - 1 ) * 100 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Charles River Laboratories International  (STU:RV6) 12-1 Month Momentum % Explanation

Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 12-1 Month Momentum % measures the total return to a stock over the past twelve months, but ignores the previous month.

The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.


Charles River Laboratories International 12-1 Month Momentum % Related Terms

Thank you for viewing the detailed overview of Charles River Laboratories International's 12-1 Month Momentum % provided by GuruFocus.com. Please click on the following links to see related term pages.


Charles River Laboratories International (STU:RV6) Business Description

Traded in Other Exchanges
Address
251 Ballardvale Street, Wilmington, MA, USA, 01887
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.

Charles River Laboratories International (STU:RV6) Headlines

No Headlines